Market Cap 52.39B
Revenue (ttm) 2.25B
Net Income (ttm) -278.16M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -12.37%
Debt to Equity Ratio 0.00
Volume 1,781,300
Avg Vol 992,616
Day's Range N/A - N/A
Shares Out 130.39M
Stochastic %K 99%
Beta 0.25
Analysts Strong Sell
Price Target $351.63

Company Profile

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference. It offers ONPATTRO and AMVUTTRA for hereditary transthyretin-mediated amyloidosis; GIVLAARI for acute hepatic porphyria; OXLUMO for primary hyperoxaluria type 1; and Leqvio for hypercholesterolemia. It also develops vutrisiran, which is in phase III clinical trial for transthyretin amyloidosis (ATTR) with cardiomyopathy; Nucresiran that is in phase I clinical trial for ATTR...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 551 8200
Fax: 617 551 8101
Address:
675 West Kendall Street, Henri A. Termeer Square, Cambridge, United States
ElliottwaveForecast
ElliottwaveForecast Aug. 4 at 6:10 AM
$ALNY expected rally in (1) of ((3)) from last month. It already reached the minimum extesion of ((3)) above 368. It should continue upside, while above 7.15.2025 low for targeting 464 to finish ((3)). https://elliottwave-forecast.com/stock-market/alny-eyes-rally-toward-368-469-zone/ #Elliottwave #Stocks
0 · Reply
kinderspiel
kinderspiel Aug. 1 at 7:02 PM
$ALNY Alnylam Pharmaceuticals Price $ 397.89 (+1.4%) Trade Count: 167 Total $ 5.18 M (90-Day Avg : 773.2 K) Call $ 4.45 M Put $ 730.6 K
0 · Reply
IN0V8
IN0V8 Aug. 1 at 6:04 PM
$ALNY Wells Fargo raises target to $395 from $333 Barclays raises target price to $460 from $329 BMO raises target price to $450 from $360 BofA Global Research raises price objective to $453 from $359 Canaccord Genuity raises target to $415 from $390 Chardan Capital Markets raises PT to $400 from Alnylam Pharmaceuticals Inc Morgan Stanley raises target to $405.00 from $312.00 Needham raises target price to $478 from $377 Piper Sandler raises target to $449 from $304 Raymond James raises target price to $424 from $370 Scotiabank raises target price to $450 from $342 Truist Securities raises target to $459 from $385 Truist Securities raises target to $459 from $385 UBS raises target price to $550 from $403
0 · Reply
ZacksResearch
ZacksResearch Aug. 1 at 4:38 PM
$ALNY jumps 15.4% on strong Q2 results! Amvuttra sales soared 114% on a reported basis, contributing to a 17% YoY revenue increase on a reported basis and crushing earnings expectations. The stock is up 66.7% YTD, far outpacing the industry’s 1.5% rise. See why ALNY’s outlook remains promising 👉 https://www.zacks.com/stock/news/2649841/alny-q2-earnings-top-estimates-on-higher-amvuttra-revenues-stock-up?cid=sm-stocktwits-2-2649841-body-5488&ADID=SYND_STOCKTWITS_TWEET_2_2649841_BODY_5488
0 · Reply
JarvisFlow
JarvisFlow Aug. 1 at 3:53 PM
UBS updates rating for Alnylam Pharmaceuticals ( $ALNY ) to Buy, target set at 403 → 550.
0 · Reply
sogenerous
sogenerous Aug. 1 at 3:17 PM
$ALNY man seeing this at 400s now and I was in this at 10. Not making that mistake again
2 · Reply
ZacksResearch
ZacksResearch Aug. 1 at 3:02 PM
$ALNY just dropped a surprise Q2 profit — and the stock’s flying Amvuttra revenues surged, and they raised 2025 revenue guidance — a bullish combo that sent shares up 15%. Full breakdown here 👉 https://www.zacks.com/stock/news/2649841/alny-q2-earnings-top-estimates-on-higher-amvuttra-revenues-stock-up?cid=sm-stocktwits-2-2649841-teaser-5401&ADID=SYND_STOCKTWITS_TWEET_2_2649841_TEASER_5401
0 · Reply
WilliamReinsch117
WilliamReinsch117 Aug. 1 at 2:45 PM
$ALNY others waiting for confirmation i’m buying WKSP NOW that’s the difference between rich and rekt 💎🙌
0 · Reply
d_risk
d_risk Aug. 1 at 1:37 PM
$ALNY - Alnylam Pharmaceuticals Inc. Common Stock - 10Q - Updated Risk Factors Alnylam’s 2025 10-Q highlights new risks tied to third-party dependencies, operational management, convertible notes complexities, stock-specific risks, and expanded focus on commercialization, financials, IP, and cybersecurity amid streamlined risk factor presentation. #Pharmaceuticals #Cybersecurity #Commercialization #ConvertibleNotes #ThirdPartyRisks 🟢 Added 🟠 Removed https://d-risk.ai/ALNY/10-Q/2025-07-31
0 · Reply
HoraceNelson278
HoraceNelson278 Aug. 1 at 1:29 PM
$ALNY every once in a while a stock just mispriced AF. this is that one. WKSP = $3. PT = $13. Float = paper. do the math 📊✅
0 · Reply
Latest News on ALNY
Alnylam: Amvuttra Is Just Getting Started

Jul 31, 2025, 3:13 PM EDT - 3 days ago

Alnylam: Amvuttra Is Just Getting Started


Alnylam Pharma Stock Outlook: Is ALNY Topping Out?

Jul 1, 2025, 9:06 AM EDT - 4 weeks ago

Alnylam Pharma Stock Outlook: Is ALNY Topping Out?


Alnylam Pharmaceuticals Names Garg R&D Chief

Jun 18, 2025, 12:04 PM EDT - 6 weeks ago

Alnylam Pharmaceuticals Names Garg R&D Chief


Alnylam Issues 2024 Corporate Responsibility Report

May 20, 2025, 9:00 AM EDT - 2 months ago

Alnylam Issues 2024 Corporate Responsibility Report


Alnylam Pharmaceuticals Ready To Go With Its Next Blockbuster

Mar 21, 2025, 5:37 PM EDT - 4 months ago

Alnylam Pharmaceuticals Ready To Go With Its Next Blockbuster


Alnylam shares rise on expanded heart drug approval

Mar 21, 2025, 7:34 AM EDT - 4 months ago

Alnylam shares rise on expanded heart drug approval


US FDA approves Alnylam's drug for rare heart condition

Mar 20, 2025, 5:59 PM EDT - 4 months ago

US FDA approves Alnylam's drug for rare heart condition


Alnylam to Webcast Presentation at Stifel 2025 Virtual CNS Forum

Mar 11, 2025, 8:00 AM EDT - 5 months ago

Alnylam to Webcast Presentation at Stifel 2025 Virtual CNS Forum


Alnylam: Waiting For Regulatory Updates In March

Feb 13, 2025, 5:01 PM EST - 6 months ago

Alnylam: Waiting For Regulatory Updates In March


ElliottwaveForecast
ElliottwaveForecast Aug. 4 at 6:10 AM
$ALNY expected rally in (1) of ((3)) from last month. It already reached the minimum extesion of ((3)) above 368. It should continue upside, while above 7.15.2025 low for targeting 464 to finish ((3)). https://elliottwave-forecast.com/stock-market/alny-eyes-rally-toward-368-469-zone/ #Elliottwave #Stocks
0 · Reply
kinderspiel
kinderspiel Aug. 1 at 7:02 PM
$ALNY Alnylam Pharmaceuticals Price $ 397.89 (+1.4%) Trade Count: 167 Total $ 5.18 M (90-Day Avg : 773.2 K) Call $ 4.45 M Put $ 730.6 K
0 · Reply
IN0V8
IN0V8 Aug. 1 at 6:04 PM
$ALNY Wells Fargo raises target to $395 from $333 Barclays raises target price to $460 from $329 BMO raises target price to $450 from $360 BofA Global Research raises price objective to $453 from $359 Canaccord Genuity raises target to $415 from $390 Chardan Capital Markets raises PT to $400 from Alnylam Pharmaceuticals Inc Morgan Stanley raises target to $405.00 from $312.00 Needham raises target price to $478 from $377 Piper Sandler raises target to $449 from $304 Raymond James raises target price to $424 from $370 Scotiabank raises target price to $450 from $342 Truist Securities raises target to $459 from $385 Truist Securities raises target to $459 from $385 UBS raises target price to $550 from $403
0 · Reply
ZacksResearch
ZacksResearch Aug. 1 at 4:38 PM
$ALNY jumps 15.4% on strong Q2 results! Amvuttra sales soared 114% on a reported basis, contributing to a 17% YoY revenue increase on a reported basis and crushing earnings expectations. The stock is up 66.7% YTD, far outpacing the industry’s 1.5% rise. See why ALNY’s outlook remains promising 👉 https://www.zacks.com/stock/news/2649841/alny-q2-earnings-top-estimates-on-higher-amvuttra-revenues-stock-up?cid=sm-stocktwits-2-2649841-body-5488&ADID=SYND_STOCKTWITS_TWEET_2_2649841_BODY_5488
0 · Reply
JarvisFlow
JarvisFlow Aug. 1 at 3:53 PM
UBS updates rating for Alnylam Pharmaceuticals ( $ALNY ) to Buy, target set at 403 → 550.
0 · Reply
sogenerous
sogenerous Aug. 1 at 3:17 PM
$ALNY man seeing this at 400s now and I was in this at 10. Not making that mistake again
2 · Reply
ZacksResearch
ZacksResearch Aug. 1 at 3:02 PM
$ALNY just dropped a surprise Q2 profit — and the stock’s flying Amvuttra revenues surged, and they raised 2025 revenue guidance — a bullish combo that sent shares up 15%. Full breakdown here 👉 https://www.zacks.com/stock/news/2649841/alny-q2-earnings-top-estimates-on-higher-amvuttra-revenues-stock-up?cid=sm-stocktwits-2-2649841-teaser-5401&ADID=SYND_STOCKTWITS_TWEET_2_2649841_TEASER_5401
0 · Reply
WilliamReinsch117
WilliamReinsch117 Aug. 1 at 2:45 PM
$ALNY others waiting for confirmation i’m buying WKSP NOW that’s the difference between rich and rekt 💎🙌
0 · Reply
d_risk
d_risk Aug. 1 at 1:37 PM
$ALNY - Alnylam Pharmaceuticals Inc. Common Stock - 10Q - Updated Risk Factors Alnylam’s 2025 10-Q highlights new risks tied to third-party dependencies, operational management, convertible notes complexities, stock-specific risks, and expanded focus on commercialization, financials, IP, and cybersecurity amid streamlined risk factor presentation. #Pharmaceuticals #Cybersecurity #Commercialization #ConvertibleNotes #ThirdPartyRisks 🟢 Added 🟠 Removed https://d-risk.ai/ALNY/10-Q/2025-07-31
0 · Reply
HoraceNelson278
HoraceNelson278 Aug. 1 at 1:29 PM
$ALNY every once in a while a stock just mispriced AF. this is that one. WKSP = $3. PT = $13. Float = paper. do the math 📊✅
0 · Reply
JarvisFlow
JarvisFlow Aug. 1 at 1:00 PM
Barclays updates rating for Alnylam Pharmaceuticals ( $ALNY ) to Overweight, target set at 329 → 460.
0 · Reply
JarvisFlow
JarvisFlow Aug. 1 at 12:30 PM
Piper Sandler updates rating for Alnylam Pharmaceuticals ( $ALNY ) to Overweight, target set at 304 → 449.
0 · Reply
JarvisFlow
JarvisFlow Aug. 1 at 11:30 AM
Chardan Capital has adjusted their stance on Alnylam Pharmaceuticals ( $ALNY ), setting the rating to Buy with a target price of 325 → 400.
0 · Reply
JarvisFlow
JarvisFlow Aug. 1 at 11:30 AM
Morgan Stanley updates rating for Alnylam Pharmaceuticals ( $ALNY ) to Equal-Weight, target set at 312 → 405.
0 · Reply
ElliottwaveForecast
ElliottwaveForecast Aug. 1 at 4:56 AM
$ALNY rallied 15% yesterday confirms strength. As long as price holds above 715.2025 low, it can rally toward 365–464 as the part of ((3)) and pullback remain supported. #ElliottWave #Stock
0 · Reply
ElliottwaveForecast
ElliottwaveForecast Aug. 1 at 4:46 AM
$ALNY showing strong bullish momentum in wave ((3)) from April 2025 low It expected rally to continue against April-2025 low and any short term pullback in 3, 7 or 11 swings find buyers for further upside. More here 👉 https://elliottwave-forecast.com/stock-market/alny-eyes-rally-toward-368-469-zone/ #ElliottWave #Stocks
0 · Reply
BIOTECH_GURU
BIOTECH_GURU Jul. 31 at 11:01 PM
$ALNY wow! Congratulations to longs here. TTR -CM is just getting started $BBIO next week! Hoping for a wild run.
1 · Reply
mayo1251
mayo1251 Jul. 31 at 9:03 PM
$ALNY do you think we will see the stock split?
0 · Reply
JarvisFlow
JarvisFlow Jul. 31 at 5:38 PM
Needham has adjusted their stance on Alnylam Pharmaceuticals ( $ALNY ), setting the rating to Buy with a target price of 377 → 478.
0 · Reply
SparkyReturns
SparkyReturns Jul. 31 at 2:40 PM
$ALNY Just sharing news. $TAK $BNTX $BIIB
0 · Reply
Doozio
Doozio Jul. 31 at 2:20 PM
$ALNY huckleberries r thru da $$$$ during 🐒🍌🧠⏰♾️
0 · Reply
StockBraker
StockBraker Jul. 31 at 2:14 PM
$ALNY Was worth the wait. Nothing but House Money left now on this one.
1 · Reply